The Fred Hollows Foundation Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2019
NCT03813069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

The Fred Hollows Foundation, Ethiopia | The Fred Hollows Foundation, UK

Active Ingredients

Drugs in Phase 4 Trials (1)

fluorometholone (fml) (1 trial)

Drugs in Phase 2 Trials (2)

3-[n-butyl-n-acetyl]-aminopropionic acid ethyl ester (1 trial)

permethrin (nix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eye Diseases (Phase 4)

Eyelid Diseases (Phase 4)

Trachoma (Phase 2)

Trichiasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3